Curanex Pharmaceuticals Inc (CURX)
↓ Download CSVKey ratios (FY2025)
-37.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$4.24M | -$365.1K | — |
| Net Income | -$4.23M | -$361.5K | — |
| EPS (Diluted) | $-0.17 | $-0.03 | — |
| Total Assets | $11.58M | $517.9K | — |
| Total Liabilities | $361.0K | $14.6K | — |
| Shareholders' Equity | $11.22M | $503.4K | $60.1K |
| Cash & Equivalents | $5.00M | — | — |
| Operating Cash Flow | -$10.48M | -$555.6K | — |
| Shares Outstanding | 28.34M | 24.00M | — |